Gyre Therapeutics, Inc. (GYRE)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-07) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-07) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-11) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-09) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-17) · 99.1 | 8-K (2025-02-18) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-26) · 99.1 | 8-K (2024-02-14) · 99.1 | ||
| 10-Q | Q3-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations (unaudited) | — |
|
| Consolidated Statements of Operations and Comprehensive (loss) Income | ||
| Consolidated Statements of Operations and Comprehensive Income | ||
| Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Condensed Consolidated Statements of Equity (unaudited) | — |
|
| Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) (unaudited) | — |
|
| Consolidated Statements of Convertible Preferred Stock and Equity | ||
| Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) (unaudited) (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Balance Sheet Components | ||
| Commitments and Contingencies | ||
| Convertible Preferred Stock | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Employee Benefit Plans | ||
| Eps | — |
|
| F351 Asset Acquisition | — |
|
| Fair Value Measurements | — |
|
| Fair Value Measurements and Financial Instruments | ||
| Financial Statements Schedule I Financial Information of Parent Company | — |
|
| Gni Usa Contributions Under The Business Combination Agreement | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | ||
| Leases | ||
| Nature of Operations and Liquidity | — |
|
| Net (loss) Income Per Share ("eps") Attributable To Common Stockholders | — |
|
| Net Income (loss) Per Share Attributable To Common Stockholders | — |
|
| Net Income Per Share ("eps") Attributable To Common Stockholders | — |
|
| Organization and Basis of Presentation | — |
|
| Organization and Nature of Operations | — |
|
| Pay Vs Performance Disclosure | ||
| Related Parties | — |
|
| Related Party Transactions | ||
| Restructuring | ||
| Revenue | ||
| Segment Information | ||
| Stock Based Compensation | ||
| Stockholders' Equity | ||
| Stockholders' Equity (deficit) | — |
|
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||